Scott Ginebaugh
CEO
Cosmica Biosciences
Cosmica Biosciences utilizes insights from space biology to accelerate drug discovery focused on longevity by studying the effects of low gravity on cellular aging. This approach aims to identify new biomarkers and therapeutic interventions that can enhance human health and lifespan on Earth.
- Artificial Intelligence
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$10.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
The study of aging and the development of effective longevity therapeutics are hampered by the slow pace of human aging studies and the difficulty of identifying relevant biomarkers. Traditional methods for evaluating anti-aging interventions often lack the speed and efficiency needed to accelerate drug discovery.
Solution
Cosmica Biosciences leverages space biology, specifically the accelerated aging observed in low-gravity environments, to expedite the discovery of novel longevity therapeutics. By studying the effects of spaceflight on cellular and organismal aging, the company identifies new biomarkers and therapeutic targets relevant to age-related diseases. This approach allows for rapid evaluation of potential anti-aging interventions and the development of strategies to enhance human health and lifespan on Earth and in space. The company aims to understand the physiological changes induced by low gravity to unlock interventions that extend human healthspan.
Target Audience
The primary audience includes pharmaceutical companies, research institutions, and space agencies focused on developing interventions for age-related diseases and ensuring astronaut health during long-duration space missions.
Features
- Utilizes spaceflight and simulated microgravity to model accelerated aging processes.
- Identifies novel biomarkers associated with aging through multi-omics analysis of space-exposed biological samples.
- Develops therapeutic interventions targeting the pathways affected by microgravity-induced aging.
- Employs computational biology and AI to analyze large datasets and predict the efficacy of potential therapeutics.
- Focuses on developing treatments for age-related diseases and enhancing human resilience for deep space exploration.